EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Case of Neural Tube Defect in Early Pregnancy Following Sulfasalazine Exposure Without Folic Acid Supplementation

Francesca Holden iD, Rodney Hughes iD

Case Reports in Rheumatology · 2026-01 · 2026 (1)

DOI: 10.1155/crrh/8352167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Rheumatology, online erschienen am 29.05.2026. Verfasst von Francesca Holden und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Ashford and St Peter's Hospitals NHS Foundation Trust, Surrey, UK. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sulfasalazine is a widely used disease‐modifying antirheumatic drug (DMARD) for inflammatory arthritis and is generally considered safe in pregnancy when co‐prescribed with folic acid. However, its antifolate effects may influence folate metabolism, which is a recognised pathway associated with neural tube defects, particularly when folate supplementation is inadequate. Case Presentation A 34‐year‐old woman conceived shortly after starting sulfasalazine without folic acid supplementation. Her pregnancy was complicated by fetal spina bifida and ventriculomegaly detected at 20 weeks’ gestation, leading to termination. She had borderline‐low serum folate before conception (3.7 μg/L). No other teratogenic exposures were identified.

Conclusion

This case highlights the importance of preconception counselling and adherence to high‐dose folic acid (5 mg daily) in women of childbearing potential receiving sulfasalazine. While causality cannot be inferred, it draws attention to a potentially modifiable factor within the multifactorial aetiology of neural tube defects. It also reinforces that medications regarded as safe in pregnancy may still be associated with preventable risk when recommended supplementation is omitted.

Schlagwörter

Stichwörter der Autor:innen

case reportfolic acidneural tube defectpregnancysulfasalazine

Autor:innen und Institutionen

  • Rheumatology Department, Ashford and St Peter's Hospitals NHS Foundation Trust, Surrey, UK.

ORCID-Profile: Francesca Holden, Rodney Hughes

Zitieren

APA

Holden, F., & Hughes, R. (2026). A Case of Neural Tube Defect in Early Pregnancy Following Sulfasalazine Exposure Without Folic Acid Supplementation. Case Reports in Rheumatology, 2026(1). https://doi.org/10.1155/crrh/8352167

Vancouver

Holden F, Hughes R. A Case of Neural Tube Defect in Early Pregnancy Following Sulfasalazine Exposure Without Folic Acid Supplementation. Case Reports in Rheumatology. 2026;2026(1). doi:10.1155/crrh/8352167

BibTeX
@article{Holden2026,
  author = {Holden, Francesca and Hughes, Rodney},
  title = {A Case of Neural Tube Defect in Early Pregnancy Following Sulfasalazine Exposure Without Folic Acid Supplementation},
  journal = {Case Reports in Rheumatology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/crrh/8352167}
}
Kostenlos starten →